Last week, Hologic HOLX earned two key regulatory approvals ... the Affirm Contrast Biopsy Software is designed to work with the company’s Selenia Dimensions and 3Dimensions systems.

Hologic (HOLX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Designed from the ground up to integrate with the Selenia ® Dimensions ® and 3Dimensions™ systems, Hologic’s Affirm Contrast Biopsy Software enables clinicians to target and acquire tissue ...

Hologic, Inc. (NASDAQ:HOLX), a leading medical technology company specializing in women's health, diagnostics, and medical imaging systems, has been navigating a complex market landscape characterized ...

Hologic, Inc. (NASDAQ:HOLX), a leading medical technology company specializing in women's health, diagnostics, and medical imaging systems, has been navigating a complex market landscape ...

MARLBOROUGH, Mass., February 18, 2025--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company ...

Hologic (HOLX) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.98 per share a year ago. These figures ...